Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Michael Rothenberg

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Current Genomics|February 3, 2011
Discovering tumor suppressor genes through genome-wide copy number analysisS Michael Rothenberg, Jeff Settleman
The Journal of Clinical Investigation|July 27, 2012
The molecular pathogenesis of head and neck squamous cell carcinomaS Michael Rothenberg, Leif W Ellisen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2015
Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib-ResponseS Michael Rothenberg, Gilbert H Daniels, Lori J Wirth
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2015
Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenibS Michael Rothenberg, David G McFadden, Edwin L Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2008
Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sitesSven Diederichs, Stephanie Jung, S Michael Rothenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2008
Modeling oncogene addiction using RNA interferenceS Michael Rothenberg, Jeffrey A Engelman, Sheila Le, et al.
Genes & Cancer|March 7, 2012
ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast CancerChristopher P Mill, Michael D Zordan, S Michael Rothenberg, et al.
The Journal of Clinical Investigation|July 23, 2013
FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinomaMatthew R Ramsey, Catherine Wilson, Benjamin Ory, et al.
The Journal of Clinical Investigation|February 5, 2011
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinomaBenjamin Ory, Matthew R Ramsey, Catherine Wilson, et al.
Head & Neck|July 16, 2013
Mutation frequency in 15 common cancer genes in high-risk head and neck squamous cell carcinomaSean M McBride, S Michael Rothenberg, William C Faquin, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Genomics|February 3, 2011
Discovering tumor suppressor genes through genome-wide copy number analysisS Michael Rothenberg, Jeff Settleman
The Journal of Clinical Investigation|July 27, 2012
The molecular pathogenesis of head and neck squamous cell carcinomaS Michael Rothenberg, Leif W Ellisen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2015
Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib-ResponseS Michael Rothenberg, Gilbert H Daniels, Lori J Wirth
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2015
Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenibS Michael Rothenberg, David G McFadden, Edwin L Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2008
Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sitesSven Diederichs, Stephanie Jung, S Michael Rothenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2008
Modeling oncogene addiction using RNA interferenceS Michael Rothenberg, Jeffrey A Engelman, Sheila Le, et al.
Genes & Cancer|March 7, 2012
ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast CancerChristopher P Mill, Michael D Zordan, S Michael Rothenberg, et al.
The Journal of Clinical Investigation|July 23, 2013
FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinomaMatthew R Ramsey, Catherine Wilson, Benjamin Ory, et al.
The Journal of Clinical Investigation|February 5, 2011
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinomaBenjamin Ory, Matthew R Ramsey, Catherine Wilson, et al.
Head & Neck|July 16, 2013
Mutation frequency in 15 common cancer genes in high-risk head and neck squamous cell carcinomaSean M McBride, S Michael Rothenberg, William C Faquin, et al.
Pageof 4